logo  
Sign in or Register

Already a member?

Sign in

Or sign in with your account on:

Not a member yet?

Register
    

Bellicum Pharmaceuticals (BLCM) is a clinical stage biopharmaceutical company focused on discovering and developing novel cellular immunotherapies for various forms of cancer, including both hematological cancers and solid tumors, as well as orphan inherited blood disorders. It is based in Houston, TX. Three other companies are scheduled for the week…
Read more...
Over the holidays, I found myself commiserating with my father about the fact that no one warns you that the human body starts to break down around age 45. We don’t bounce back from an injury like we used to, and those small, irritating pains become “conditions” that must be…
Read more...
Histogenics (HSGX) is a regenerative medicine company focused on developing and commercializing products in the musculoskeletal segment of the marketplace. It is headquartered in Waltham, MA. No other companies are scheduled for the week of Dec. 1, 2014. The full IPO calendar is available at IPOpremium. Manager, Joint-managers: Cowen and…
Read more...
Being temporarily burned by the U.S. Food and Drug Administration can be a mixed blessing for a biotech with a good product in the pipeline. In an interview with The Life Sciences Report, Chen Lin, publisher of the investor newsletter What is Chen Buying? What is Chen Selling?, explains how…
Read more...
Micro-cap stocks suffer from all sorts of ills. They are often illiquid, and companies can be unable to raise new funds under reasonable terms, if at all. Investing in these equities requires extraordinary expertise and experience, and that is where micro-cap investment banker Richard "Dick" Huebner excels. In this interview…
Read more...
With delicious aromas wafting from the kitchen and holiday cheer all around, there’s nothing better than spending Thanksgiving at home among loved ones. However, if you’re stranded at an airport or stuck in traffic on your way home, it’s easy to become a Thanksgiving Grinch. Fortunately, even if you’re far…
Read more...
Second Sight Medical Products (EYES) is a medical device company that develops, manufactures and markets implantable visual prosthetics to restore some functional vision to blind patients. The company is based in Sylmar, CA. Eight other companies are scheduled for the week of Nov. 17, 2014. The full IPO calendar is…
Read more...
A working knowledge of molecular biology is essential for a biotech investor, but it helps when someone with deep knowledge of science and medicine can bring understanding to the people who commit capital to growth ideas. George Zavoico of MLV & Co. has that advantage, having been a senior investigator…
Read more...
What do you get when you combine a top-ranked industry analyst with a retired lieutenant colonel from the U.S. Marine Corp.? You get Steve Brozak, who brings his one-of-a kind perspective on the intricacies of Ebola virus disease to this interview with The Life Sciences Report. His military background, combined…
Read more...
NeuroDerm, Ltd. (NDRM) is a clinical-stage pharmaceutical company developing next-generation treatments for central nervous system, or CNS, disorders through proprietary formulations based on existing drugs that are intended to make a significant difference in patients' lives. It is based in Rehovot, Israel. Nine other companies are scheduled for the week…
Read more...
PRA Health Sciences (PRAH) is one of the world's leading global contract research organizations (CROs) by revenue, providing outsourced clinical development services to the biotechnology and pharmaceutical industries. It is based in Raleigh, NC. Nine other new companies are scheduled for the week of Nov. 10, 2014. The full IPO…
Read more...
When the biotechnology market hit a speed bump in early 2014, every stock in the sector was jolted. Large-cap biotech and big pharma have largely recovered, but small- and micro-cap companies haven't yet entirely recouped the losses. The performance of Streetwise Reports' Biotechnology Watchlist to date reflects this trend: The…
Read more...
Page 1 of 48

About us

Equities.com is the most advanced interactive online social ecosystem for the financial industry, serving as a resource center and next-generation communication platform that connects self-directed investors with public issuers, market experts, and professional service providers and vendors. Registered members can leverage our exclusive proprietary research tools such as the Small-Cap Stars, which outperformed 90% of all small-cap mutual funds, and robust do-it-yourself E.V.A. research reports. The Equities.com Issuer Dashboard is the ideal tool to communicate and manage investor awareness campaigns to the investment community, as well as to access valuable resources to help your company grow.

Market Data powered by QuoteMedia.
Copyright © QuoteMedia. Data delayed 15 minutes unless otherwise indicated. Terms of Use.